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Abstract
Merozoite Surface Protein 1 is expressed on the surface of malaria merozoites and is important for invasion of the malaria
parasite into erythrocytes. MSP1-specific CD4 T cell responses and antibody can confer protective immunity in experimental
models of malaria. In this study we explore the contributions of cathepsins D and E, two aspartic proteinases previously
implicated in antigen processing, to generating MSP1 CD4 T-cell epitopes for presentation. The absence of cathepsin D, a
late endosome/lysosomal enzyme, is associated with a reduced presentation of MSP1 both following in vitro processing of
the epitope MSP1 from infected erythrocytes by bone marrow-derived dendritic cells, and following in vivo processing by
splenic CD11c+ dendritic cells. By contrast, processing and presentation of the soluble recombinant protein fragment of
MSP1 is unaffected by the absence of cathepsin D, but is inhibited when both cathepsin D and E are absent. The role of
different proteinases in generating the CD4 T cell repertoire, therefore, depends on the context in which an antigen is
introduced to the immune system.
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Introduction
Protective immunity against blood-stage malaria is dependent
on CD4 T cells and B cells [1]. In Plasmodium chabaudi (AS)
infections in mice, development of IFNc-producing Th1 cells and
antibody are required to control parasitemia. CD4 Th1 T cells are
also implicated in driving inflammatory responses linked to
pathology. Despite the importance of CD4 T cells in malaria
infections, the factors governing their activation, differentiation
and regulation are not fully understood.
The primary activation of CD4 T cells requires that the antigen
is processed and presented by dendritic cells (DC) [2]. Protein
antigens are taken up by endocytosis or phagocytosis, and cleaved
by intracellular proteinases to yield short peptides 10–20 amino
acids in length. The peptides bind to class II Major Histocom-
patibility Complex (MHC) within endosomes, and the peptide/
MHC complex is then displayed at the cell surface for subsequent
recognition by specific T cells. The interaction between a specific
T cell receptor and its cognate MHC/peptide complex is the
primary recognition driving subsequent T cell activation, differ-
entiation and proliferation.
Despite the central importance of antigen processing in the
overall CD4 T response, many of the details of which enzymes are
required, their specificity, and their role in shaping the repertoire
of the response, remain unclear. Understanding these intracellular
events is nevertheless important, since the repertoire of peptides
displayed can influence the response both quantitatively and
qualitatively.
MSP1 is expressed as a 200 kD protein on the surface of
merozoites [3]. All but the C-terminal 19 kD fragment (MSP119)i s
cleaved shortly before the merozoite invades the RBC [4]. MSP119
is considered as a malaria vaccine candidate and in rodents, high
levels of specific antibody can confer protection [4]. In natural
human infections, however, MSP119-specific antibody responses
can be short-lived and comparatively low, despite repeated
exposure to infection [5].
The tightly folded structure of MSP119 is stabilized by five or six
disulfide bonds which can limit antigen processing and, thereby,
may affect the generation of CD4+ T cells providing help for B
cells [6]. In Plasmodium chabaudi, the equivalent to the P.falciparum
C-terminal MSP119, PcMSP121, contains some CD4 T cell
epitopes which requires processing in the phago/lysosome and
de novo class II MHC synthesis, whilst processing of another
region of MSP1, for example within the less structurally
constrained 38kd fragment can take place in recycling endosomes
[7]. Here we examine the potential role of two proteinases,
cathepsins D and E, in processing of the merozoite surface antigen,
PcMSP1. These two enzymes are members of the aspartic acid
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However, they are located within different sub compartments of
the endolysosomal system. Cathepsin D is a classical late
endosome/lysosomal enzyme, targeted to this compartment via
the mannose-6-phosphate receptor. In contrast, active cathepsin E
is found predominantly in earlier endosomal structures [8]. In this
study we combine genetic and pharmacological inhibition to probe
the role of the two enzymes in processing of full length cell-
associated PcMSP1 and soluble recombinant PcMSP121 fragment.
Unexpectedly, the context in which the protein is processed
determines the role of these two enzymes in generating antigenic
peptides leading to recognition by CD4 T cell hybridomas and IL-
2 secretion.
Results
Cathepsin D deficient mice die between days 20–23 of life due
to progressive neuronal degeneration [9]. In order to study
immunological function in healthy adult mice, we made radiation
chimeras by transferring bone marrow cells from wild type or
cathepsin D deficient BALB/c donors into lethally irradiated wild
type BALB/c recipients. In these chimaeras the haematopoetic
compartment is reconstituted by donor cells, and spleen, thymus
and bone marrow-derived DC express undetectable levels of
cathepsin D. In contrast, non- haematopoetic tissues such as liver
show normal cathepsin D levels (Fig. 1). These mice are healthy,
and do not develop any obvious neurological or other overt
abnormality. The immune system of the mice contains normal
numbers of T cells, B cells, DC and macrophages, have normal
levels of antibody and normal T-dependent antibody response to
ovalbumin and sheep RBC [10].
We first examined the ability of bone marrow generated DC
from wildtype or cathepsin D-deficient chimaeras to process and
present PcMSP121 epitopes to specific CD4 T cell hybridomas,
either from P. chabaudi-infected RBC, or from recombinant
MSP121 protein. Bone-marrow derived DC from deficient mice
expressed no detectable cathepsin D, but were obtained in normal
numbers, and had a similar cell surface phenotype to their
cathepsin D expressing counterparts (Fig. 2).
The processing activity of the DC was assessed by measuring the
response of the MSP1 specific T cell hybridomas, B7 and B5. The
B7 epitope (MSP1aa 1690–1709) is located within the C-terminal
MSP121 domain, while the B5 peptide (MSP1aa 1157–1171) is
located within the more N-terminal 38kd fragment.
Cathepsin D deficiency significantly impaired the ability of DC
to process and present both the B7 epitope and B5 epitope of
MSP1 from iRBC (Fig. 3A and 3B). In contrast, processing of
recombinant protein MSP121 or synthetic peptide was unaffected,
and the IL-2 response of B7 was similar with both cathepsin D
deficient and sufficient DC (Fig. 3C).
Since we do not have access to a cathepsin E deficient mouse,
we used a targeted inhibitor MPC6 [8,11] to investigate whether
the recombinant MSP1 protein was instead processed by cathepsin
E. This inhibitor inhibits both cathepsin D and E, but no other
known proteinase within DC. Inhibition of processing in cathepsin
D deficient mice would therefore indicate a requirement for
cathepsin E. MPC6 partially inhibited the processing/presentation
of PcMSP121, (Fig. 4), suggesting a requirement for cathepsin E in
the processing of this protein. The inhibitor did not affect
presentation of exogenously added B7 peptide, confirming that the
effect was due to processing rather than to inhibition of some other
later step in the antigen presenting pathway. We could not test the
B5 hybridoma in this model, since the B5 epitope lies outside the
PcMSP121 fragment (cf [7]).
These data together suggest that the processing pathways/
enzymes involved in processing of intact PcMSP1 on the surface of
iRBC and the enzymes required to process the PcMSP121recom-
binant protein fragment are different.
Figure 1. Haemopoeitic cells from CTSD 2/2 donor chimeras
do not express CTSD. Spleen, thymus, liver and bone marrow DC
from CTSD 2/2 and CTSD +/+ donor chimeras was fractionated by
SDS-PAGE, and analysed by Western blot for expression of CTSD (left
panels) and CTSE (right panels, as loading controls). One of four
experiments.
doi:10.1371/journal.pone.0024886.g001
Figure 2. The phenotype of bone marrow derived DC is not affected by absence of CTSD. Bone marrow cells from CTSD 2/2 and CTSD +/
+ donor chimeras were cultured in GM-CSF for seven days, purified on CD11c magnetic beads, and then analysed for expression of surface markers by
flow cytometry. Cells were .80% CD11c positive. Shaded histogram: isotype control. Solid line : CTSD 2/2 DC. Dotted line CTSD +/+ DC. One of
three experiments.
doi:10.1371/journal.pone.0024886.g002
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processing of MSP1 in vivoina P. chabaudi infectionofBALB/cmice.
Wildtype or cathepsin D deficient chimeras were infected with P.
chabaudi. After 8 days, the mice were sacrificed and splenic CD11c+
DC were isolated by cell magnetic bead sorting (.90% CD11c
purity) and cocultured with the B7 or B5 hybridomas. Proportion
and numbers of DC subsets in the spleen were similar in both WT
and cathepsin D in deficient mice at peak parasitemia (Fig. 5). In
addition, class II levels on the DC were the same indicating that the
DC recruitment and activation during malaria infection was not
different in wt and cathepsin D deficient mice (Fig. 5).
DC from infected cathepsin D deficient mice were significantly
less efficient at activating both B7 and B5 hybridomas (Fig. 6A).
However, DC from both sets of mice were equally effective at
activating the T cells when exogenous peptide antigen was added
in vitro (Fig. 6B), indicating that the defect resulted from a reduced
ability to process MSP1 antigen, and not a general defect in
antigen presenting activity. Despite the reduced ability of DC from
P. chabaudi - infected cathepsin D deficient mice in presenting
MSP1 to T cell hybridomas, no significant differences were found
in parasitemias between infected WT and cathepsin D deficient
mice (Fig. 7A) in the first 16 days of infection. However later in
Figure 3. Absence of CTSD impairs the ability of DC to process erythrocytes infected with P. chabaudi merozoites in vitro. A) DC (10
3)
from CTSD 2/2 and CTSD +/+ donor chimeras were co-cultured with B7 T hybridoma cells (2610
4) and different numbers of iRBC. IL-2 release was
measured after 24 hours using the indicator cell line CTLL. B) DC from CTSD 2/2 and CTSD +/+ donor chimeras were cocultured with iRBC (5
erythrocytes/DC) for three hours, and then different numbers of DC were co-cultured with B7 or B5 hybridoma cells as in A. C) DC (10
3) from CTSD 2/2
and CTSD +/+ donor chimeras were co-cultured with B7 T hybridoma cells (2610
4) and different concentrations of MSP1 protein or a peptide coding for
the B7 epitope at different concentrations. IL2 was release was measured as above. An additional intermediate concentration of MSP1 (50 mg/ml) was
also testedinadditionalexperimentswithsimilarresults. Pvaluesshowthe differencebetweenCTSD+/+andCTSD2/2analysedbyAnova.Oneoffour
experiments.
doi:10.1371/journal.pone.0024886.g003
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parasitemia.
IgG responses to whole parasite lysate and MSP121 protein were
measured in plasma from infected wildtype or cathepsin D
deficient chimeric mice at day 36 post infection. Unexpectedly,
antibody responses were enhanced in the absence of cathepsin D
(Fig. 7B and 7C). This coincided with the reduced parasitemia,
suggesting that the increased Ab response might be limiting
parasitemia.
Discussion
In this study we demonstrate that the absence of cathepsin D
significantly inhibits the T cell response to two epitopes of P.
chabaudi cabaudi MSP1 antigen, either after processing of infected
erythrocytes by bone marrow derived DC in vitro, or by splenic DC
during in vivo infection. By contrast, processing of soluble
recombinant PcMPS121 fragment is unaffected by the absence of
cathepsin D, but is inhibited by an inhibitor which can inhibit both
cathepsin D and E. This is the first reported example in which the
processing mechanism for a specific epitope is shown to depend
not just on its context within a protein, but on the context in which
the protein is processed.
Cathepsin D is a lysosomal enzyme present at high concentra-
tions within late endosomes, lysosomes and phago-lysosomes [12].
Its importance for lysosomal degradation is demonstrated by the
fact that deficiency of the enzyme leads to a lysosomal-storage type
disease, with progressive neural degeneration both in animals and
man [13]. The role of cathepsin D in antigen processing has
remained equivocal. Previous studies of antigen processing in
cathepsin D deficient mice did not show any major defects [14],
although one subsequent study suggested a role in processing of a
Mycobacterial heat shock protein [15]. However, no previous
studies have directly addressed a role for this enzyme in processing
of particulate antigen, despite its known localisation to the
phagolysosome. The data presented in this study are consistent
with a model in which the malaria parasite, P. chabaudi in the form
of free merozoites or within infected RBC are phagocytosed by
DC (either in vitro or in vivo) and then processed to provide peptide
epitopes for binding to class II MHC within the phagolysosome or
endosome. Cathepsin D contributes to this processing step,
although other enzymes can partially substitute for it, at least in
its absence. In the case of the B7 epitope, which is within the
disulfide bond-rich highly compact part of MSP1, processing may
also require reduction of disulfide bonds, and the disulfide
isomerise gamma-interferon-inducible lysosomal thiol reductase
also found within late endosomes/lysosomes [16]. However,
processing of both the B7 epitope within the compact PcMSP121
domain, and B5, which is found within the less structured 38kd
fragment, is reduced in the absence of cathepsin D. Thus this
enzyme may play a dominant role in phagolysosomal protein
fragmentation.
In contrast to cathepsin D, cathepsin E is absent from late
endosomes/lysosomes, and is found either in immature form in the
endoplasmic reticulum, or in a poorly defined sub-compartment of
the early endosome [8]. The role of cathepsin E in antigen
processing has been reported in several previous studies [8,17–19],
although a cathepsin E deficient mouse has only recently been
generated [20]. Interestingly, the processing of different epitopes of
ovalbumin show differential sensitivity to inhibition of cathepsin E,
and the epitope which shows maximal cathepsin E requirement is
found within a compact protein domain which is tightly folded
with disulfide bonds similar to the B7 epitope within MSP1.
Further studies will be required to determine whether this is a
general feature of cathepsin E sensitive epitopes.
A paradoxical finding of our study was that the absence of
cathepsin D leads to reduced processing, but does not impair
either malaria specific IgG production or parasite clearance.
Indeed the IgG levels against MSP121 and whole parasite lysate
appear enhanced, and parasite numbers at later times points
slightly reduced. The mechanisms underlying this observation
must remain speculative. However, absence of cathepsin D is likely
to have broader effects on both self and non-self repertoire of the
CD4 compartment than just the two epitopes investigated in this
study. This in turn may affect both the qualitative and quantitative
nature of the overall T cell response to the P.chabaudi infection.
Further studies will be required to understand this effect fully. The
observation highlights our limited understanding of the mecha-
nisms which underly antigen processing, how this determines the
repertoire of the responding T cells, and how in turn this is
Figure 4. The aspartic proteinase inhibitor MPC6 inhibits processing of PcMSP121. Bone marrow DC (10
3) from CTSD +/+ donor chimeras
were cocultured with differing concentrations of (A) PcMSP121 protein or (B) a peptide coding the B7 epitope (1 mg/ml) and MPC6 (5 mM) for three
hours and then colcultured with B7 hybridoma cells. p values show the significance value comparing presence and absence of inhibitor (Anova). One
of three experiments. (C)_Bone marrow DC from CTSD +/+ donor chimeras were cocultured with iRBC (5 and 30 erythrocytes/DC) for three hours, and
then the DC (10
3) were cocultured with B7 hybridoma cells. p values show the significance value comparing presence and absence of inhibitor
(Anova). One of two experiments.
doi:10.1371/journal.pone.0024886.g004
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steps is important for designing more effective immunological
strategies to control infection by malaria.
Materials and Methods
Plasmodium chabaudi chabaudi clone AS (originally obtained from
Dr. K.N. Brown, National Institute for Medical Research,
London) was routinely injected from frozen stocks. Infections
were initiated by intraperitoenal injection of 10
5 RBC (infected red
blood cells) obtained from infected mice before the peak of
parasitaemia, as described previously [21]. Thin blood films were
made from tail blood and stained with Giemsa R66 (BDH, Poole,
GB) solution to monitor the course of parasitaemia.
Isolation of P. chabaudi infected RBC (iRBC). Blood was collected
from BALB/c mice infected with P. chabaudi at day 7 of infection.
Contaminating leukocytes were removed using Plasmodipur filters
(Euro-Diagnostica, UK) and late trophozoite stage iRBC were
enriched by centrifugation on 74% isotonic Percoll (Amersham
Biosciences,UK) as described previously [22]. Purity of trophozo-
ite-infected RBC as assessed by Giemsa was greater than 95%
pure.
Recombinant PcMSP121 protein was expressed in Pichia pastoris
as described previously [5].
Figure 5. Normal numbers and class II MHC expression of DC isolated from spleens of P. chabaudi infected CTSD 2/2 and CTSD +/+
donor chimeras. DC were isolated from spleens of CTSD 2/2 and CTSD +/+ donor chimeras using magnetic CD11c beads, and stained for CD11c,
CD8 and I-A
d using flow cytometry. Total numbers of cells isolated were similar in both sets of chimeras (3.83610
6 in CTSD +/+, and 4.5610
6 in CTSD
2/2 for experiment shown, one representative of two).
doi:10.1371/journal.pone.0024886.g005
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Harlan UK and kept in the Biological Services, UCL. Mice
carrying a neomycin insertion in the cathepsin D gene [9] were
bred onto the BALB/c background for ten generations, and then
maintained as a heterozygote inbred colony. Homozygotes could
be identified by day 19 or 20 by their small size, and reduced
mobility. Genotype was confirmed in each case by PCR as
described. All experiments were carried out under UK Animal
Project Licence authorization.
Bone marrow radiation chimaeras. Recipient BALB/c mice
were kept on acidified water (0.01% conc. HCl in H20) for 1 week
prior to transfer. The mice were irradiated with 8 Gy (delivered
over 15–30 minutes) with an X-ray source (A.G.O. HS X-RAY
SYSTEM, Reading, UK) and then allowed to recover for 4–
5 hours, before receiving 2610
6 bone marrow cells from cathepsin
D deficient, or wild type litter-mates, intravenously in 0.2 ml PBS.
The chimaeric mice were maintained for a minimum of 2–3
months in order to allow full reconstitution of the immune system
[10].
Dendritic cell culture. Dendritic cells were obtained by culture
of bone marrow cells (5610
5/ml) in Iscove’s medium (Gibco BRL
(Invitrogen Life Technologies/Life Sciences), Paisley, UK), 10%
FCS (Gibco BRL) with the addition of GM-CSF (20 ng/ml;
PeproTech, Rocky Hill, NJ, USA). Fresh medium and cytokine
were added on day 4 and dendritic cells were harvested on days 7/
8. Dendritic cells were further purified by magnetic cell sorting,
using mouse CD11c
+ microbeads (CD11c (N418), Miltenyi Biotec,
Bergisch Gladbach, Germany) and the appropriate columns (MS
separation columns, Miltenyi Biotec), according to the manufac-
ture’s guidelines. The enriched population was 85 to 95%
CD11c
+.
Measurement of P. chabaudi and PcMSP121 specific IgG
antibodies. Plasma was collected 36 days after a primary P.
chabaudi infection. ELISA assays to measure malaria-specific IgG
antibodies were performed as described previously [5,6]. For the
MSP1 ELISA, monoclonal anti MSP121 antibody, NIMP23 was
used as standard for determining the concentration of MSP121-
specific IgG [23] . Plasmodium chabaudi hyperimmune plasma was
used as the standard to determine anti parasite lysate IgG and its
antibody binding capacity was defined as 1000 U [6]. Plasma from
uninfected BALB/c mice was used as a negative control. Specific
IgG antibodies were detected using alkaline phosphatase (AP)-
conjugated goat anti-mouse IgG antibodies (Southern Biotechnol-
ogy, Birmingham, AL, USA) and p-nitrophenyl phosphate
substrate (PNPP, Sigma). The data are represented as the mean
IgG antibody units from individual mice.
Splenic dendritic cells. Spleens were dissected from mice at day
8 after i.p. infection with 10
5 P. chabaudi, and treated for 30 min at
37uC with 0.4 mg/ml of Liberase CI (Roche, Basel, Switzerland)
in serum-free Iscove’s Modified Dulbecco Medium (IMDM)
Figure 6. In vivo processing of MPS1 by CTSD 2/2 splenic DC is impaired. DC were isolated from spleens of CTSD 2/2 and CTSD +/+ donor
chimeras 8 days after infection of the mice with P. chabaudi. A) The purified DC were co-cultured with B5 or B7 hybridoma cells and without any
additional exogenous antigen and IL2 production measured after 24 hours, using the CTLL indicator cell line. B) As in A but peptide coding the B7 or
B5 epitopes (1 mM) was added in vitro. P values for comparison of CTSD+/+ and CTSD 2/2 by ANOVA. One experiment of two.
doi:10.1371/journal.pone.0024886.g006
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500 g for 10 min, cell pellets were re-suspended for 5 min in
8.3 g/L NH4Cl in 0.01 M Tris-HCl pH 7.5 to lyse RBC. Spleen
cells were washed, incubated with Fc receptor (FcR) block
followed by anti-CD11c magnetic beads and enrichment on
magnetic columns (Miltenyi Biotec, Bergisch Gladbach, Germany)
to more than 95% purity.
Western blotting. Western blots were performed on liver, spleen
thymus or BMDC homogenate, prepared using a Dounce
homoginiser. Protein (30 ug as measured by Bradford assay) were
loaded in each lane and separated by 12% denaturing SDS
polyacrylamide gel electrophoresis (PAGE) under reducing
conditions. Proteins were transferred electrophoretically to
nitrocellulose membranes and then immunostained using standard
procedures. Primary antibodies used were: monoclonal rat anti-
mouse Cathepsin D (R&D System, Minneapolis, MN, US, 4 mg/
ml); rabbit anti-rat Cathepsin E antibody (WAKO, Neuss,
Germany), diluted 1:1000. Primary antibodies were detected
using HRP-conjugated rabbit anti-rat IgG or goat anti-rabbit IgG
(DAKO, Glostrup, Denmark, diluted 1:2000), and ECL detection
reagent (Amersham Pharmacia Biotech, Bucks, UK). For
quantification, gels were scanned and digital images analyzed
using Image J software [24].
Cell lines , peptides and MPC6. CTLL-2 cells, B5 hybridoma
recognising aa 1137–1151 in the p38 fragment of MSP1 and B7 T
cell hybridoma recognising aa 1673–1694 in the MSP121 fragment
[7] were cultured in IMDM (Sigma, Dorset, Poole) supplemented
with 10 percent FCS, 1 mM L-glutamine, 10 mM Hepes,
5610
25 M 2-Mercaptoethanol, 100 mg/ml penicillin,100 U/ml
streptomycin and 1 mM sodium pyruvate. CTLL-2 cells were
cultured with 10 U/ml human recombinant IL-2. B5 peptide
(ISVLKSRLLKRKKYI) and the B7 peptide (RCEKDTEATC-
SINKGGCDPS) were synthesized by Jerini AG. Berlin. MPC6
was synthesised as previously described [11].
Flow cytometry Single cell suspensions of purified CD11c+ DC
or bone marrow derived DC were resuspended in FACS buffer
(0.5% w/v BSA, 2 mM EDTA, 0.05% sodium azide in PBS).
5610
5 cells were pre-incubated at room temp for 10 min with
anti-Fc R block. All other antibody incubation steps were 20 min
on ice. The following antibodies were used, at concentrations
recommended by manufacturer : CD11b APC conjugate, clone
M1/70, BD pharm, isotype: rat IgG2b; CD11c: PE-Cy7
conjugate, clone N418, eBioscience, isotype: hamster IgG ; 3.
CD40 FITC conjugate, clone HM40-3, BD pharm, isotype: IgM;
CD80:
FITC conjugate, clone 16-10A1, BD pharm, isotype: hamster
IgG2 I-Ad.
The cells were acquired on a BD LSR II Flow Cytometer (BD
Biosciences) and analysed with FlowJo software (TriStar).
Antigen presentation assay using B5 and B7 T cell hybridomas.
Different numbers of bone marrow or splenic CD11c+ DCs were
incubated with 2610
4 T cell hybridoma cells (Costar), in a 7
percent CO2 incubator and at 37uC for 24 h. As positive controls,
similar numbers of DCs were incubated with 1 mM peptide. The
supernatants were then collected, frozen, thawed and added to
5000 CTLL-2 cells per well in IMDM supplemented with 10
Figure 7. CTSD deficient, malaria infected mice have decreased late parasitaemia and enhanced malaria specific IgG responses. A)
CTSD 2/2 and CTSD +/+ donor chimeras were infected with P. chabaudi, and percent parasitaemia measured at different days post infection as
shown. Geometric mean and standard error of mean is shown (n=6). Significance was measured using the Mann Whitney test. B) and C. As in A, but
plasma was collected after 36 days for ELISA against whole parasite lysate (B) or PcMPS121 protein (C). Each individual mouse, and the geometric
mean and standard error of mean (n=6) is shown. One experiment of two , each with six mice in each group.
doi:10.1371/journal.pone.0024886.g007
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pulsed with 1 mCi
3H Thymidine (Amersham) for 16 hr and
proliferation determined as previously described [6].
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